Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Plinabulin PK/PD in Docetaxel-treated NSCLC with Neutropenia Risk
CTR20171049Phase 2Completed
- Sponsor
- BeyondSpring Inc.
- Start
- Oct 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of plinabulin in non-small cell lung cancer (NSCLC), chemotherapy-induced neutropenia (CIN), sponsored by BeyondSpring Inc.. Started Oct 2017; status: completed.
02
Drugs
plinabulin
03
Conditions
non-small cell lung cancer (NSCLC)chemotherapy-induced neutropenia (CIN)
Beyond the preview
Go deeper on CTR20171049.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20171049.